These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 15334474

  • 1. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis.
    Clancy RM, Backer CB, Yin X, Chang MW, Cohen SR, Lee LA, Buyon JP.
    Arthritis Rheum; 2004 Aug; 50(8):2598-603. PubMed ID: 15334474
    [Abstract] [Full Text] [Related]

  • 2. Neonatal lupus erythematosus syndrome: analysis of C4 allotypes and C4 genes in 18 families.
    Watson RM, Scheel JN, Petri M, Lee LA, Bias WB, McLean RH.
    Medicine (Baltimore); 1992 Mar; 71(2):84-95. PubMed ID: 1545698
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus.
    Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, Nyberg F.
    Arthritis Rheum; 2005 Nov; 52(11):3639-45. PubMed ID: 16255056
    [Abstract] [Full Text] [Related]

  • 4. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.
    McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K.
    Ann Rheum Dis; 2006 Apr; 65(4):488-94. PubMed ID: 16107511
    [Abstract] [Full Text] [Related]

  • 5. Neonatal lupus erythematosus: HLA-DR and -DQ distributions are different among the groups of anti-Ro/SSA-positive mothers with different neonatal outcomes.
    Miyagawa S, Shinohara K, Kidoguchi K, Fujita T, Fukumoto T, Yamashina Y, Hashimoto K, Yoshioka A, Sakurai S, Nishihara O, Shirai T.
    J Invest Dermatol; 1997 Jun; 108(6):881-5. PubMed ID: 9182815
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry.
    Neiman AR, Lee LA, Weston WL, Buyon JP.
    J Pediatr; 2000 Nov; 137(5):674-80. PubMed ID: 11060534
    [Abstract] [Full Text] [Related]

  • 7. Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus.
    Zampieri S, Alaibac M, Iaccarino L, Rondinone R, Ghirardello A, Sarzi-Puttini P, Peserico A, Doria A.
    Ann Rheum Dis; 2006 Apr; 65(4):545-8. PubMed ID: 16096331
    [Abstract] [Full Text] [Related]

  • 8. Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus.
    Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GR, Hawk JL, McGregor JM.
    Lupus; 2001 Apr; 10(7):473-9. PubMed ID: 11480844
    [Abstract] [Full Text] [Related]

  • 9. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
    Sontheimer RD.
    Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
    [Abstract] [Full Text] [Related]

  • 10. Drug-induced lupus erythematosus.
    Vedove CD, Del Giglio M, Schena D, Girolomoni G.
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [Abstract] [Full Text] [Related]

  • 11. Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study.
    Drosos AA, Dimou GS, Siamopoulou-Mavridou A, Hatzis J, Moutsopoulos HM.
    Ann Med Interne (Paris); 1990 Jan; 141(5):421-4. PubMed ID: 2256585
    [Abstract] [Full Text] [Related]

  • 12. Race differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus from the aspect of Japanese studies.
    Furukawa F, Yamamoto Y, Kanazawa N, Muto M.
    Ann N Y Acad Sci; 2009 Sep; 1173():552-6. PubMed ID: 19758198
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C.
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [Abstract] [Full Text] [Related]

  • 14. Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription.
    Werth VP, Zhang W, Dortzbach K, Sullivan K.
    J Invest Dermatol; 2000 Oct; 115(4):726-30. PubMed ID: 10998151
    [Abstract] [Full Text] [Related]

  • 15. HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy.
    Munthe-Kaas MC, Carlsen KL, Carlsen KH, Egeland T, Håland G, Devulapalli CS, Akselsen H, Undlien D.
    Allergy; 2007 Sep; 62(9):991-8. PubMed ID: 17686102
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM, Kanninen P, Jeskanen L, Koskenmies S, Panelius J, Hasan T, Ranki A, Saarialho-Kere U.
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [Abstract] [Full Text] [Related]

  • 17. The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I.
    Gerl V, Hostmann B, Johnen C, Waka A, Gerl M, Schumann F, Klein R, Radbruch A, Hiepe F.
    Arthritis Rheum; 2005 Feb; 52(2):531-8. PubMed ID: 15692985
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus.
    Castaño-Rodríguez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM.
    Autoimmun Rev; 2008 Feb; 7(4):322-30. PubMed ID: 18295738
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis.
    Shibue T, Tsuchiya N, Komata T, Matsushita M, Shiota M, Ohashi J, Wakui M, Matsuta K, Tokunaga K.
    Arthritis Rheum; 2000 Apr; 43(4):753-7. PubMed ID: 10765919
    [Abstract] [Full Text] [Related]

  • 20. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK.
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.